USRE34307EExpiredUtility
Device for orbital implant
Priority: Oct 19, 1987Filed: May 3, 1991Granted: Jul 6, 1993
Est. expiryOct 19, 2007(expired)· nominal 20-yr term from priority
A61F 2/141A61F 2310/00293A61L 27/12
2
PatentIndex Score
8
Cited by
17
References
20
Claims
Abstract
Highly satisfactory orbital comprising granular hydroxyapatite and spheres of porous, low density hydroxyapatite are described. The implants are useful in enucleation and envisceration procedures. In enucleation procedures, the implants can be sutured to the eye muscles by either insertion in a scleral sac or other suitable container or, in the cast of spherical hydroxyapatite, sutured to the eye muscles by means of holes in the spheres. After healing, the implant is drilled to receive a peg for fixing an artificial eye to the implant to complete the prosthesis.
Claims
exact text as granted — not AI-modifiedWe claim:
1. An orbital implant comprising a monolithic sphere of sterile, low density, porous hydroxyapatite of a size suited for insertion into the orbital socket to replace an eye removed therefrom.
2. An implant according to claim 1, wherein the sphere is obtained from coral or other synthetic means.
3. An implant according to claim 1 wherein the material is sewn within a scleral sac, preserved dura, or other homologous or autologous collagen graft material.
4. An implant according to claim 1 wherein the sphere is adapted to receive an artificial eye.
5. An implant according to claim 4 wherein the sphere is provided with a hole to receive a peg for fixing an artificial eye to the implant.
6. An implant according to claim 1 wherein the sphere is provided with holes to permit the direct suturing of eye muscles to the sphere.
7. An implant according to claim 6 wherein the sphere is provided with a hole to receive a peg for fixing an artificial eye to the implant.
8. A prosthesis comprising an orbital implant according to claim 1 to which is fixed an artificial eye.
9. A surgical process comprising evisceration of an eye and filling the scleral sac with a monolithic sphere of sterile, porous, low density hydroxyapatite of a size suited for insertion into the scleral sac to replace the contents of the eviscerated eye.
10. A process according to claim 9 wherein the implant is adapted to receive an artificial eye.
11. A process according to claim 10 wherein the implant is provided with a hole to receive a peg to which is fixed to the artificial eye.
12. A process according to claim 10 wherein the artificial eye is fixed to the implant.
13. A surgical process comprising enucleation of an eye and its replacement by an orbital implant comprising a monolithic sphere of sterile, porous, low density hydroxyapatite of a size suited for replacement of the enucleated eye sewn within a container selected from the group consisting essentially of a scleral sac, preserved dura, homologous or autologous graft material.
14. A process according to claim 13 wherein the container is sutured to the eye muscles.
15. A process according to claim 13 wherein the sphere is provided with holes and, using such holes, sutured directly to the eye muscles.
16. A process according to claim 13 wherein the sphere is sewn within a container selected from a scleral sac, preserved dura or other homologous or autologous graft material and the container sutured to the eye muscles.
17. A process according to claims 13, 14, 15 or 16 wherein the implant is adapted to receive an artificial eye.
18. A process according to claim 17 wherein the implant is provided with a hole to received a peg to which is fixed the artificial eye.
19. A process according to claim 18 wherein the artificial eye is fixed to the implant. .Iadd.
20. A surgical process comprising filling the scleral sac of an eviscerated eye with a monolithic sphere of sterile, porous, low density hydroxyapatite of a sized suited for insertion into the scleral sac to replace the contents thereof. .Iaddend. .Iadd.21. A process according to claim 20 wherein the implant is adapted to receive an artificial eye. .Iaddend. .Iadd.22. A process according to claim 21 wherein the implant is provided with a hole to receive a peg to which is fixed the artificial eye. .Iaddend. .Iadd.23. A process according to claim 22 wherein the artificial eye is fixed to the implant. .Iaddend. .Iadd.24. A surgical process comprising replacing an enucleated eye with an orbital implant comprising a monolithic sphere of sterile, porous, low density hydroxyapatite of a size suited for replacement of the enucleated eye. .Iaddend. .Iadd.25. A process according to claim 24 wherein the implant is sewn within a container selected from a scleral sac, preserved dura, homologous graft material or autologous graft material and the container is sutured to the eye muscles. .Iaddend. .Iadd.26. A process according to claim 24 wherein the sphere is provided with holes and, using such holes, sutured directly to the eye muscles. .Iaddend. .Iadd.27. A process according to claims 24, 25, or 26 wherein the implant is adapted to receive an artificial eye. .Iaddend. .Iadd.28. A process according to claim 27 wherein the implant is provided with a hole to receive a peg to which is fixed an artificial eye. .Iaddend. .Iadd.29. A process according to claim 28 wherein the artificial eye is fixed to the implant. .Iaddend.Join the waitlist — get patent alerts
Track USRE34307E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.